JP2024522368A5 - - Google Patents

Info

Publication number
JP2024522368A5
JP2024522368A5 JP2023575560A JP2023575560A JP2024522368A5 JP 2024522368 A5 JP2024522368 A5 JP 2024522368A5 JP 2023575560 A JP2023575560 A JP 2023575560A JP 2023575560 A JP2023575560 A JP 2023575560A JP 2024522368 A5 JP2024522368 A5 JP 2024522368A5
Authority
JP
Japan
Prior art keywords
agent according
group
agent
independently
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032738 external-priority patent/WO2022261257A1/en
Publication of JP2024522368A publication Critical patent/JP2024522368A/ja
Publication of JP2024522368A5 publication Critical patent/JP2024522368A5/ja
Pending legal-status Critical Current

Links

JP2023575560A 2021-06-08 2022-06-08 ステープルペプチドおよびその方法 Pending JP2024522368A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163208487P 2021-06-08 2021-06-08
US63/208,487 2021-06-08
US202163224834P 2021-07-22 2021-07-22
US63/224,834 2021-07-22
US202263303952P 2022-01-27 2022-01-27
US63/303,952 2022-01-27
PCT/US2022/032738 WO2022261257A1 (en) 2021-06-08 2022-06-08 Stapled peptides and methods thereof

Publications (2)

Publication Number Publication Date
JP2024522368A JP2024522368A (ja) 2024-06-18
JP2024522368A5 true JP2024522368A5 (cg-RX-API-DMAC10.html) 2025-06-17

Family

ID=84425507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575560A Pending JP2024522368A (ja) 2021-06-08 2022-06-08 ステープルペプチドおよびその方法

Country Status (9)

Country Link
US (1) US20240360179A1 (cg-RX-API-DMAC10.html)
EP (1) EP4355350A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024522368A (cg-RX-API-DMAC10.html)
KR (1) KR20240031957A (cg-RX-API-DMAC10.html)
BR (1) BR112023025528A2 (cg-RX-API-DMAC10.html)
CA (1) CA3218824A1 (cg-RX-API-DMAC10.html)
IL (1) IL308790A (cg-RX-API-DMAC10.html)
MX (1) MX2023014679A (cg-RX-API-DMAC10.html)
WO (1) WO2022261257A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
AU2019326423A1 (en) 2018-08-20 2021-04-08 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
US20260207704A1 (en) * 2022-12-15 2026-07-23 Parabilis Medicines, Inc. Stapled peptides and methods thereof
WO2024130217A1 (en) * 2022-12-15 2024-06-20 Fog Pharmaceuticals, Inc. Stapled peptides and methods thereof
WO2024130224A2 (en) * 2022-12-16 2024-06-20 Purdue Research Foundation Stapled peptides for sensitization of cancer to treatment
JP2026520144A (ja) * 2023-06-06 2026-06-22 パラビリス メディシンズ, インコーポレイテッド ステープルペプチドおよびその方法
WO2025265097A1 (en) * 2024-06-20 2025-12-26 Parabilis Medicines, Inc. Stapled peptides and methods thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508531B1 (en) * 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
EP3549951A3 (en) * 2008-12-09 2019-11-20 Dana Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
EP3782638A1 (en) * 2013-03-13 2021-02-24 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
WO2016085280A1 (ko) * 2014-11-28 2016-06-02 서울대학교산학협력단 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도
US10011631B2 (en) * 2015-12-01 2018-07-03 The University Of Hong Kong Stapled helical peptides and methods of synthesis
BR112020004555A2 (pt) * 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
CN111447941B (zh) * 2017-10-27 2023-10-31 俄亥俄州国家创新基金会 用于细胞内递送装订肽的多肽缀合物
AU2019326423A1 (en) * 2018-08-20 2021-04-08 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
CA3186681A1 (en) * 2020-07-22 2022-01-27 Brian Halbert WHITE Stapled peptides and methods thereof

Similar Documents

Publication Publication Date Title
CN119119239A (zh) 制备gip/glp1双重激动剂的方法
EP3514167B1 (en) Thrombospondin 1-binding peptide
BR112020004567A2 (pt) polipeptídeos para o tratamento de doenças
JP7604368B2 (ja) ストレス症候群、免疫反応症候群及び卒中症候群の処置のためのポリペプチド
JP2024522368A (ja) ステープルペプチドおよびその方法
CN119136833A (zh) 膜易位结构域及其用途
JP4303958B2 (ja) 環状ペプチドとその調製方法並びに血管形成阻害薬又は促進薬としての用途
JP3584358B2 (ja) ポリエチレングリコール−ヒルジン結合体、その製造法及び血栓症の治療への使用
KR20220137876A (ko) 조직 재생의 촉진에 유용한 hmgb1과 관련된 폴리펩티드, 이를 포함하는 조성물, 및 이들의 용도
EP4410816A1 (en) Peptide
CN107592865B (zh) 中和流感病毒的拟肽化合物
CN109069577B (zh) Hiv进入的d-肽抑制剂以及使用方法
CN104877015B (zh) 一种三萜-多肽缀合物、其药物组合物及用途
CN111848778B (zh) 特立帕肽类似物
EP1572743B1 (en) Peptides and their use for the treatment of hiv infections
KR102043992B1 (ko) Ncoa1/stat6 단백질-단백질 상호작용을 저해하는 신규 스테이플 펩타이드 및 이의 용도
JP2015502378A (ja) Hiv膜融合阻害剤
CN111153960B (zh) 一种a型肉毒毒素抑制剂及其制备方法与应用
HK40131453A (en) Process for preparing a gip/glp1 dual agonist
JP5044765B2 (ja) 新規ペプチド、これを用いたエンドトキシン由来疾患治療剤およびこの治療剤の探索方法
CN113164613B (zh) 二聚的肽-磷脂缀合物的优化方法
HK40130839A (en) Process for preparing a gip/glp1 dual agonist
CN121914245A (zh) 具有抗癌作用的多肽及其应用
JPH10182479A (ja) ペプチド誘導体類からなる薬剤
WO1998043995A1 (en) Novel anti-hiv complexes and medicinal compositions